Carotid Intima Media Thickness, Inflammatory Markers, and Endothelial Activation Markers in HIV Patients with Lipoatrophy Increased at 48 Weeks Regardless of Use of Rosiglitazone or Placebo

Rosiglitazone may be useful for the treatment of antiretroviral therapy-associated lipoatrophy, but an association with cardiovascular disease (CVD) has been questioned in diabetics. We evaluated rosiglitazone's effect on surrogate markers of CVD in HIV-infected individuals with lipoatrophy. HI...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Tungsiripat, Marisa, El-Bejjani, Dalia, Rizk, Nesrine, Dogra, Vikram, O'Riordan, Mary Ann, Ross, Allison C., Hileman, Corrilynn, Storer, Norma, Harrill, Danielle, McComsey, Grace A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Mary Ann Liebert, Inc. 2011
Gaiak:
Preclinical Studies/Drug Development
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3064528/
https://ncbi.nlm.nih.gov/pubmed/20969457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2010.0187
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak